Skip to main content

MoneyWorks4Me

Welcure Drugs & Pharmaceuticals informs about statement of investor grievances

08 Oct 2024 Evaluate
Welcure Drugs & Pharmaceuticals has informed that the statement of Investor Grievances pursuant to Regulation 13 (3) of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015 as provided by its Registrar and Transfer Agent - Skyline Financial Services for the quarter and half year ended 30th September, 2024 is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Redington 335.15
Adani Enterprises 2696.65
Amrapali Industries 32.23
Maxgrow India 164.55
Rashi Peripheral 633.10
View more..